D-1362-2014 Class I Terminated
FDA drug recall D-1362-2014 was initiated by Pharmakon Pharmaceuticals on Mar 26, 2014 and is designated Class I. Reason for recall: Superpotent Drug: Product contains twice the stated amount of midazolam. The recall status is terminated (terminated Jul 31, 2014). Affected quantity: 80 syringes.
Recall Details
- Product Type
- Drugs
- Report Date
- Jun 18, 2014
- Initiation Date
- Mar 26, 2014
- Termination Date
- Jul 31, 2014
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 80 syringes
Product Description
Midazolam 0.2 mg/2 mL 0.9% Sodium Chloride syringes, Total dosage: 0.4 mg per 2 mL, Rx Only, Pharmakon Pharmaceuticals, Inc., 14450 Getz Rd, Noblesville, Indiana, NDC 45183-0014-69.
Reason for Recall
Superpotent Drug: Product contains twice the stated amount of midazolam.
Distribution Pattern
IN
Code Information
Lot #: E1016227C, Exp. 4/21/2014; E0433735C, Exp. 4/20/2014
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1362-2014
- openFDA file date
- Oct 23, 2026
- Loaded by RegDataLab
- Oct 26, 2026